The global CAR T-cell therapy market is experiencing significant growth, fueled by increasing acceptance of this innovative approach for a range of malignancies. Key trends shaping the market include rising prevalence of cancer, advancements in science, and supportive regulations. The market is characterized by a fragmented landscape with numerous